Biotech

All Articles

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's dive into a discussion with Ayla Ellison, Strong Biotech Editor-in-Chief and also Michelle...

New records show how Bayer's asundexian failed to prevent strokes

.Bayer suspended the period 3 test for its own element XIa prevention asundexian late in 2014 after ...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is still set on taking its various sclerosis (MS) med tolebrutinib to the FDA, executives ha...

Galapagos' stockpile as fund reveals intent to shape its own progression

.Galapagos is coming under added stress coming from financiers. Having actually developed a 9.9% ris...

Cell- centered Sana scoops very first CSO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, firings and al...

Allist pays off Jacobio $21M, landing role in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has acquired itself a starring role in China's KRAS market, spendin...

ReNeuron leaving behind purpose swap after missing out on fundraising goal

.ReNeuron has joined the lengthy listing of biotechs to leave Greater london's intention securities ...

MBX apply for IPO to take opposition to Ascendis in to stage 3

.MBX Biosciences has actually added to the recent flurry of IPO filings. The biotech, which submitte...

FDA broadens probing right into Lykos' MDMA tests: WSJ

.For Lykos Therapeutics as well as the firm's would-be MDMA-assisted treatment for post-traumatic st...

Gene publisher Volume laying off 131 workers

.Merely times after gene publisher Tome Biosciences revealed hidden working cuts, a more clear image...